Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures | ||||
U.S. Dollars in thousands, except per share amounts | ||||
| ||||
| Three months ended | Six months ended | ||
| Jun 30, | Jun 30, | ||
| 2023 | 2022 | 2023 | 2022 |
| Unaudited | Unaudited | Unaudited | Unaudited |
GAAP net loss | $ (5,818) | $ (1,123) | $ (10,690) | $ (2,819) |
Equity-based compensation expense included in cost of
| 390 | 344 | 794 | 683 |
Equity-based compensation expense included in research
| 2,420 | 2,006 | 4,593 | 4,001 |
Equity-based compensation expense included in sales
| 468 | 340 | 861 | 673 |
Equity-based compensation expense included in general
| 927 | 613 | 1,816 | 1,335 |
Amortization of intangible assets related to acquisition
|
702 |
1,282 |
1,379 |
2,564 |
Costs associated with the Intrinsix and VisioSonics
|
312 |
325 |
638 |
651 |
Loss associated with the remeasurement of marketable
|
119 |
527 |
236 |
1,398 |
NRE revenues associated with the purchase price
|
0 |
0 |
0 |
42 |
Non-GAAP net income (loss) | $ (480) | $ 4,314 | $ (373) | $ 8,528 |
GAAP weighted-average number of Common Stock
| 23,476 | 23,174 | 23,405 | 23,139 |
Weighted-average number of shares related to
| — | 820 | — | 795 |
Weighted-average number of Common Stock used in
| 23,476 | 23,994 | 23,405 | 23,934 |
|
|
|
|
|
|
|
|
|
|
GAAP diluted loss per share | $ (0.25) | $ (0.05) | $ (0.46) | $ (0.12) |
Equity-based compensation expense | $ 0.18 | $ 0.14 | $ 0.34 | $ 0.28 |
Amortization of intangible assets related to acquisition of
|
$ 0.03 |
$ 0.06 |
$ 0.06 |
$ 0.11 |
Costs associated with the Intrinsix and VisioSonics
|
$ 0.01 |
$ 0.01 |
$ 0.03 |
$ 0.03 |
Loss associated with the remeasurement of marketable
|
$ 0.01 |
$ 0.02 |
$ 0.01 |
$ 0.06 |
Non-GAAP diluted earnings (loss) per share | $ (0.02) | $ 0.18 | $ (0.02) | $ 0.36 |